Enzyme UBE2N Shows Promise as Natural Defense Against Fatty Liver Disease Progression
Fatty liver disease affects an estimated 100 million Americans, ranging from benign fat accumulation to more dangerous inflammatory conditions. A new study has identified an enzyme that may act as a natural brake against disease progression.
The enzyme, called UBE2N, helps liver cells perform two critical functions: removing damaged mitochondria—the cell's energy-producing structures—and breaking down fat. When these processes work properly, the liver can prevent the inflammation, scarring, and cell damage associated with MASH (Metabolic dysfunction-associated steatohepatitis), the more severe form of the disease.
The discovery suggests that boosting UBE2N activity could be a potential therapeutic strategy for treating fatty liver disease before it advances to more dangerous stages. While more research is needed to translate these findings into treatments, the identification of this natural defense mechanism provides new insight into how the liver protects itself from metabolic damage.